focus -WSS

focus

author：Wikipedia 2025-08-07 16:19:01 - browse：78427

Gavel and Stethoscope due process — District courts will make the first round of decisions soon on challenges to Medicare's drug price negotiation program. APStock

WASHINGTON — Pharmaceutical companies’ efforts to scuttle President Biden’s signature health care achievement, empowering Medicare to negotiate prescription drug prices, will soon face their first big tests.

District court judges could soon weigh in on the litany of court cases that major companies filed against the government — shedding light on whether drugmakers have any hope of postponing the first parts of the negotiation process, scrapping it entirely, or sending the issue up to the Supreme Court.

It’s a major moment for the Biden administration, too, as the White House ramps up its efforts to take credit for the new changes in the 2024 election. The first round of legal decisions will play out in the thick of campaign season, attorneys told STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： What affirmative action's end means to a medical student

Wikipedia

entertainment

WSS

Dogs on Prozac: What pet anti

Close Medicare's dangerous gaps in addiction treatment coverage

After traumatic brain injury, life support decisions can use more time

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Bird flu in milk supply is likely coming from asymptomatic cows

hotspot

focus

leisure time

United colonoscopy coverage change 'may cost lives,' doctors say

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

FDA approval of Sarepta Duchenne genetic therapy gives me hope

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

Medical records are filled with copy

AstraZeneca lung cancer study comes in below expectations

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Crowdfunding for unproven stem cell procedures spreads misinformation

Trump demands the U.S. pay no more for drugs than other countries … again

Use doctors trained outside the U.S. to ease the physician shortage

focus

FTC falls short on scrutinizing hospital mergers, study says

Cancer researcher Catriona Jamieson is sending tumors into space

Dexcom's push to bring CGM to type 2 diabetes patients

UnitedHealth financials solid despite Change Healthcare cyberattack

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Health care needs a new profession: neuroimaging counseling

Wikipedia

entertainment

entertainment

focus